CS Paper Radar

Learning Who Benefits Most: Multi-Treatment Causal Ranking for Population Health Stratification

Rocco Zaccagnino, Martina Girolamo, Alberto Lombardi, Delfina Malandrino, Donatello Telesca, Alessia Ture

cs.LG ·submitted 2026-10-14 08:31 UTC · v1

Abstract

Population health stratification frameworks, such as the Italian DM77, organize patients by clinical need and care pathways but offer limited guidance on which care changes to prioritize under constrained resources. We present PROMETHEUS (Proactive Resource Optimization through Multi-treatment Effect-based Targeting in Healthcare Environments Using Stratification), a framework that formulates population health stratification as a multi-treatment causal ranking problem. Its objective is to order eligible patient-treatment opportunities by expected incremental benefit rather than obtain perfectly calibrated individual treatment-effect estimates. Each clinically admissible care intensification is compared with maintaining the patient's current pathway. Treatments are learned jointly to produce a globally comparable ranking across patients and care profiles, within domains sharing a reference condition, outcome, follow-up horizon, and benefit scale. This separates clinical need, treatment benefit, and resource-constrained allocation. PROMETHEUS combines doubly robust causal signals with a Siamese neural ranking model and contrastive representation pretraining. The shared representation captures similarities across care transitions, supporting prioritization under capacity constraints. Synthetic experiments and semi-synthetic experiments using real administrative covariates from ASL Benevento evaluate ranking quality, allocation value, robustness, and failure modes. The results support the framework's ability to recover generated benefit orderings and prioritize care opportunities in the evaluated settings. PROMETHEUS provides a preclinical approach to actionable stratification; validation with observed treatment-outcome data is required before clinical use.

Comment
19 pages, 1 figure, 19 tables

Closest papers

Nearest neighbours by meaning across the whole index.

CaMeWM: A Causal Medical World Model for Generative Tumor Evolution and Treatment Planning

cs.CV cs.LG ·2026-10-17 ·Huanlong Gao, Xuelei He, Fengjun Zhao, Xiaowei He
similarity 0.64
Abstract · 30 pages,8 figures,12 tables,including supplementary material

Treatment planning is intrinsically counterfactual: clinicians must compare how a patient's tumor and survival would evolve under competing regimens, whereas a retrospective cohort records only the regimen received and one follow-up scan. A treatment-conditioned generator trained on such data can therefore reproduce historical treatment allocation rather than simulate the interventional disease dynamics needed to rank regimens. We introduce \textbf{CaMeWM}, a causal medical world model for supported post-TACE tumor evolution and treatment planning. CaMeWM implements one intervention-to-decision loop rather than three independent prediction tasks: it first admits a queried regimen only for clinically comparable histories with empirical treatment support; it then generates a distribution of lesion-local follow-up worlds through an action-conditioned response descriptor, deterministic anchor, and residual 3D diffusion transition; and it finally maps sampled worlds to restricted mean survival time (RMST) with a response-Cox utility model. Under pre-treatment adjustment and positivity, this loop estimates a prespecified, support-restricted g-formula target; all selection and nuisance estimation are fold-local, and the induced policy is evaluated by cross-fitted, censoring-adjusted doubly robust estimation. Across 79 paired out-of-fold episodes, CaMeWM achieves 0.618 SSIM and 0.528 change-map SSIM for follow-up CT transition, while its generated-world survival pathway attains a 0.615 C-index; factual-only AIPW estimates a 9.60-week RMST gain (95\% CI 0.61--18.13) for the frozen policy. CaMeWM provides an inspectable basis for retrospective, support-restricted treatment planning.

0.33

Precedence-Aware Resource Allocation: Extending the AUTOC Framework to Multi-Level Treatments

cs.LG cs.AI ·2026-10-26 ·Olin E. Gilster, Shengpu Tang
similarity 0.63
Abstract

Many real-world decision problems require allocating limited resources across individuals to maximize total benefit often through interventions that vary in intensity rather than binary treat-or-not decisions. In these settings, higher levels treatments require first applying lower levels of treatment, inducing a precedence constraint that complicates allocation under a fixed budget. While the causal inference literature has largely emphasized accurate estimation of conditional average treatment effects (CATE), recent work has shown that estimation accuracy alone does not guarantee effective resource allocation, motivating ranking-based evaluation frameworks. The Area Under the Targeting Operating Characteristic (AUTOC) provides an effective way to evaluate prioritization rules across budget levels, but existing formulations are limited to binary treatments. We introduce Multi-Level AUTOC (ML-AUTOC), which is a generalization for AUTOC designed for multi-level treatment settings with precedence. We also propose precedence-aware policies for mapping true marginal treatment effects to feasible treatment assignments under fixed budget constraints. Our results show that in the setting of multi-level treatments, maximizing realized treatment effects may require re-allocation of treatments across individuals.

0.24

Expert-Guided g-computation with Large Language Models for Estimating Causal Effects on Timings: Applications to Hospital Quality Improvement

cs.AI stat.MEstat.AP ·2026-08-11 ·Patrick Vossler, Jialin Ouyang, F. Richard Guo, Anran Huang, Ali Shojaie +3 more
similarity 0.62
Abstract

Hospital quality improvement (QI) programs routinely face multiple candidate interventions to optimize hospital flow, but existing methods struggle to estimate and rank the causal effects of such interventions. This work focuses on one of the most standard hospital metrics, the average length of stay (LOS), and its causal estimand, the average time saved. To characterize this causal effect, qualitative approaches rely on expert judgment to map patient trajectories, making them susceptible to cognitive biases; quantitative approaches rely on data-driven models, which fail when interventions are hypothetical with no historical data or have complex causal mechanisms that require clinical reasoning rather than data alone. We propose expert-guided g-computation, or egg-computation, which combines the complementary strengths of both approaches by connecting the Gantt charts commonly used to map patient trajectories with the causal DAG literature. We introduce a causal model over Gantt charts and establish identification using a variant of g-computation that seeks expert input only for components unidentifiable from data. To make egg-computation practical, we develop an LLM-assisted pipeline that reliably scales up expert reasoning. In simulations, egg-computation outperforms conventional causal inference methods when patients have diverse causal structures and intervention mechanisms. In a study of eleven candidate QI interventions at an urban safety-net hospital, the LLM pipeline generated graphs and time-saving estimates highly concordant with those of human experts. Beyond healthcare, egg-computation is a broadly applicable framework for estimating the average time saved for candidate interventions whose causal mechanisms can be represented using Gantt charts.

0.04

SIRNET: Causal Adaptation of Pretrained Embeddings for Semiparametric Treatment-Effect Estimation Under Surrogacy

cs.LG stat.ME ·2026-09-29 ·Lei Shi, Qiuran Lyu
similarity 0.60
Abstract

Modern experiments increasingly produce rich post-treatment objects---such as text, images, and video---that may provide early surrogate signals for outcomes that are delayed, expensive, or observed only for a subset of participants. A pretrained encoder can turn such an object into a strong generic embedding, but the embedding is not trained for the estimation tasks required by a causal estimator and may emphasize information irrelevant to the causal target. We propose SIRNET, a Surrogate-Informed Representation adaptation framework for neural-NETwork-based causal estimation in the presence of unstructured post-treatment surrogates. Starting from pretrained surrogate embeddings, SIRNET learns a shared adapter jointly for outcome prediction, treatment propensity, and arm-specific surrogate marginalization, beyond the generic pretraining objective. The resulting covariate and surrogate representations provide a common interface for these nuisance tasks. The final treatment-effect estimate and confidence interval are obtained from cross-fitted orthogonal scores that attain the semiparametric efficiency bound under the stated nuisance-rate conditions. We also validate SIRNET's performance in synthetic and semisynthetic experiments, as well as the Anti-Amyloid in Asymptomatic Alzheimer's Disease (A4) trial, using frozen pretrained brain-MRI embeddings as surrogates for a long-term outcome.

0.26

From Prediction to Incrementality: Causal Optimization for Large-Scale Targeting and Recommendation

cs.LG cs.AI ·2026-08-10 ·Changshuai Wei, John Bencina, Phuc Nguyen, Andre Assuncao Silva T Ribeiro, Benjamin Zelditch
similarity 0.60
Abstract

Large-scale targeting and recommendation systems are typically built around predictive scores fed into heuristic or local allocation. When the business goal is incremental impact, as in marketing campaigns, incentives, and notifications, this paradigm systematically misallocates resources toward users who would have acted anyway. We present a decision-centric framework that instead optimizes causal effects under global constraints, aligning three components under a single objective: a causal neural network with a Transformer backbone for individual treatment-effect estimation, a Bayesian neural-bandit layer for uncertainty-aware exploration, and a dual-based large-scale linear-programming layer for constrained allocation. The framework also supports sequential context and multi-outcome, attribute-conditioned scoring through a Transformer encoder and outcome embeddings. We evaluate it with offline simulations on a public bandit dataset, targeted architectural ablations, and an online A/B test on LinkedIn Feed marketing traffic. We also distill production lessons on causal training-data construction and cost and delivery control, which were critical to successful deployment. The end-to-end treatment policy delivered a statistically significant $+7.20\%$ lift in the primary long-term-value metric, demonstrating the feasibility of production-scale causal optimization under business constraints.

0.04

A Foundation Model for Policy In-Context Longitudinal Causal Effect Estimation

cs.AI ·2026-10-23 ·Wenxin Chen, Kyra Gan, Mingyu Lu, Zilin Jing, Fei Wang +3 more
similarity 0.60
Abstract

Longitudinal causal effect estimation is complicated by time-varying confounding and treatment-confounder feedback loops. Existing methods generally require data-specific nuisance-model fitting, and many are tailored to prespecified treatment sequences or prediction horizons, leading to time-consuming computation at deployment. We introduce *Policy In-Context Longitudinal causal Effect estimation with Prior-data Fitted Networks* (**PICLE-PFN**), the first foundation model for longitudinal causal effect estimation that supports *dynamic* treatment policies. PICLE-PFN represents target policies through in-context history-decision demonstrations, providing a unified interface for a broad class of treatment policies. Pretrained over synthetic data sampled from longitudinal structural causal models, PICLE-PFN amortizes causal effect estimation across datasets, policies, and horizons. Given a new observational dataset and target policy, it directly predicts conditional average potential outcomes (CAPOs) in one forward pass without task-specific training or hyperparameter tuning. Across synthetic and semi-synthetic longitudinal benchmarks, PICLE-PFN achieves competitive RMSE and substantially improved uncertainty calibration with a fraction of deployment runtime, compared to state-of-the-art conventional estimators trained and tuned separately for each dataset.

0.13

Causal multi-modal AI for personalized chemosensitivity prediction

cs.AI ·2026-09-11 ·Dhruva Biswas, Jeroen Berrevoets, Alec McClean, Linus Bao, Jungkyu Park +29 more
highly cited similarity 0.59
Abstract

Chemotherapy improves survival for some patients with breast cancer, but doctors cannot reliably predict who. Current guidelines rely on recurrence scores as a proxy for treatment benefit, which may contribute to the overprescription of chemotherapy. Here we present a causal multi-modal AI model that predicts personalized chemosensitivity using routinely collected pathology and clinical information. We developed our model on a multi-national dataset of 9,141 patients (twelve cohorts, nine countries) and evaluated it on another 1,994 patients (five cohorts, three countries). The model generated treatment-specific recurrence probabilities for each patient, with near-perfect calibration and strong prognostic discrimination across both 5- and 10-year follow-up horizons. Moreover, its chemotherapy benefit predictions demonstrated robust predictive performance, and out-performed existing recurrence-score-based tests. Compared to the standard of care, using the model to support personally tailored therapeutic decisions could reduce the number of patients receiving chemotherapy by 30% while achieving the same recurrence-free rate. Tumors predicted to be highly chemosensitive displayed concordant molecular and morphological programs of proliferation, cell cycle progression, and replication stress. The model's predictive capabilities transferred zero-shot to non-breast cancers, indicating our causal multi-modal AI approach may provide a universal strategy to predict treatment outcomes across cancer types.

0.52

Representation Learning for Sample-Efficient CATE Estimation by Leveraging Multiple Outcomes

cs.LG ·2026-09-05 ·Maitreyi Swaroop, Shikha Bhat, Samantha Rodriguez, Tamar Krishnamurti, Bryan Wilder
theory similarity 0.59
Abstract

Estimating conditional average treatment effects (CATE) enables efficient targeting of interventions, but many applications have limited experimental samples, making it difficult to estimate heterogeneous effects from high-dimensional covariates. In such settings, policymakers and medical practitioners often succumb to the curse of dimensionality or apply off-the-shelf dimension reduction methods that may not preserve treatment heterogeneity. Yet these domains often come with large historical datasets measuring a wide range of outcomes -- a source of supervision that is rarely exploited in practice. Following causal representation learning, we hypothesize that such domains with high-dimensional covariates have lower-dimensional underlying dynamics. We can thus leverage the diverse outcomes measured in historical data to learn a lower-dimensional representation of the covariates. Theoretically, we prove that when the auxiliary outcomes satisfy a set of surrogacy conditions and the representation retains relevant covariate information, the original CATE is identified when the high-dimensional covariates are replaced by the learned representation. Combined with existing dimension-dependent rates for CATE estimation, the result implies greater sample-efficiency on the same experimental sample. Additionally, we characterize the bias-variance tradeoff when the assumptions do not hold perfectly, and show that the representation-based estimator can still achieve lower error when the reduction in estimator variance outweighs the bias due to compression. Empirically, we evaluate the method on synthetic data and semi-synthetic medical data.

0.21